Current Report Filing (8-k)
April 14 2017 - 3:01PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported):
April 14, 2017
MEDICAL
TRANSCRIPTION BILLING, CORP.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
|
333-192989
|
|
22-3832302
|
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
7
Clyde Road, Somerset, New Jersey, 08873
(Address
of principal executive offices, zip code)
(732)
873-5133
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Item
5.07
|
Submission
of Matters to a Vote of Security Holders:
|
The
Company held its Special Meeting of Shareholders on April 14, 2017 in Somerset, New Jersey. There were 10,423,511 shares of Common
Stock outstanding on January 23, 2017, the record date. The proposals considered at the Special Meeting are described in detail
in the Special Proxy Statement filed on February 7, 2017. The proposals described below were voted upon at the Special Meeting
and the number of votes cast with respect to each proposal was as follows:
1.
Granting the Board of Directors, in its sole discretion, to approve an amendment to the Company’s Certificate of Incorporation
to effect a reverse stock split:
|
For
|
|
|
Against
|
|
|
Abstain
|
|
|
% of Shares Voted
|
|
|
Total Shares Voted
|
|
|
|
8,266,560
|
|
|
|
231,168
|
|
|
|
7,579
|
|
|
|
81.60
|
%
|
|
|
8,505,307
|
|
2.
Approve the adoption of the Amended and Restated Equity Incentive Plan:
|
For
|
|
|
Against
|
|
|
Abstain
|
|
|
% of Shares Voted
|
|
|
Total Shares Voted
|
|
|
|
5,694,778
|
|
|
|
1,239,037
|
|
|
|
10,571
|
|
|
|
66.62
|
%
|
|
|
6,944,386
|
|
SIGNATURE(S)
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
|
|
|
Medical
Transcription Billing, Corp.
|
|
|
|
|
|
|
Date:
April 14, 2017
|
|
By:
|
/s/
Mahmud Haq
|
|
|
|
|
Mahmud
Haq
|
|
|
|
|
Chairman
of the Board and Chief Executive Officer
|
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Dec 2024 to Jan 2025
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Jan 2024 to Jan 2025
Real-Time news about CareCloud Inc (NASDAQ): 0 recent articles
More Medical Transcription Billing, Corp News Articles
